Navigation Links
Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
Date:8/23/2007

/p>

liver cancer;

* Selected lead candidates for our drug discovery program focused on

developing inhibitors of heparin binding proteins, and presented animal

data at the American Association of Cancer Research meeting. Progen

expects to submit an Investigational New Drug application to the FDA by

the end of the calendar year 2008.

"This past fiscal year was the most significant and successful in Progen's history," said Justus Homburg, Chief Executive Officer of Progen Pharmaceuticals. "Our positive Phase 2 results for PI-88 in liver cancer, combined with our considerable fundraising efforts, have effectively positioned us to initiate our Phase 3 Trial during this calendar year and continue aggressively pursuing the development, registration and commercialisation of PI-88. At the completion of the trial, we expect to have a registration package for PI-88 in over a dozen countries."

Fiscal 2007 Financial Results:

Progen's operating loss for the year ended 30 June 2007 was $22.5 million, as compared to $7.6 million in 2006. The operating loss from continuing operations, excluding the non-recurring compensation of $11.7 million paid to Medigen in 2007, amounted to $10.7 million, as compared to $7.0 million in 2006, representing a 53.6 percent increase from last year. Of the $11.7 million paid to Medigen, $11.4 million was non-cash and included equity payments and the return of our investment in Medigen.

The operating loss includes expenses of $2.2 million, as compared to $369,000 in 2006 for costs associated with preparations for the Phase 3 development of PI-88, including regulatory, additional animal studies and manufacturing.

Fiscal 2007 revenue and other income totalled $3.8 million, as compared to $2.8 million in 2006, a 33.9 percent increase. This increase was due to a 41.2 percent increase in revenue from a previously received Australian government grant, and a 58.3 percent increase in interest inco
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
2. Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
3. Progens Phase 2 Liver Cancer Trial Exceeds Efficacy Objective
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 Although lung ... the world, there are only 18 drugs in the ... Almita and Avastin are nearing their patent expiry in ... therapeutics market offers vast potential that drug manufacturers are ... treatment of small cell lung cancer (SCLC) and non-small ...
(Date:3/3/2015)... , March 3, 2015 ImmunoCellular Therapeutics, ... Andrew Gengos , Chief Executive Officer of ImmunoCellular, will ... 27 th Annual ROTH Conference on Tuesday, March ... Hotel, Laguna Niguel , CA.   ... the ROTH presentation, please log on through a link ...
(Date:3/3/2015)... , March 3, 2015 Chrono Therapeutics ... an investment by Rock Health , the leading ... of Chrono,s SmartStop™ programmable transdermal drug delivery system and ... Smoking kills more than 500,000 Americans each year, ... in the United States . Of ...
Breaking Medicine Technology:Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th 2Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology 2Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology 3
... N.J., Sept. 28 Laureate Pharma, Inc., ... company, today announced the appointment of Steven ... Mr. Johnson will be responsible for Laureate,s ... business development and project management, supporting the ...
... JUNCTION, N.J., Sept. 28 Tamir Biotechnology, Inc. ... Corporation) announced today that scientists supported by the ... reported test results confirming two of our lead ... cell culture and plaque reduction assay (the gold ...
Cached Medicine Technology:Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development 2New Discovery Targets Cytomegalovirus (CMV) 2New Discovery Targets Cytomegalovirus (CMV) 3New Discovery Targets Cytomegalovirus (CMV) 4
(Date:3/3/2015)... (PRWEB) March 03, 2015 United Benefit ... organization, is pleased to welcome The Gehring Group, Inc. ... consulting services for more than 20 years, The Gehring ... benefits and risk management consulting firm that serves organizations ... and risk management programs. , Based in ...
(Date:3/3/2015)... Grants Pass, OR (PRWEB) March 03, 2015 ... and stroke severity* confirms what water advocate and radio ... believes that dehydration – lack of sufficient water in ... affect as much as 90 percent of the US ... that dehydration is a factor in nearly all disease, ...
(Date:3/3/2015)... Everett, WA (PRWEB) March 03, 2015 ... dedication to a lifestyle of fitness and exercise. Community ... an article presenting 6 ways that families in ... fit during the winter months. , CHC says, ... for grilled chicken and steamed veggies, many families wonder ...
(Date:3/3/2015)... 2015 Prophecy Healthcare®, Inc., the ... care testing, is now conducting dedicated research to ... result of acquiring the exam rights and Intellectual ... 2014, the research will soon create more health ... providers, healthcare staffing organizations and more. ...
(Date:3/3/2015)... 03, 2015 Extend Nutrition, a leading nutritional ... amount of calories consumed at the next meal by an ... There are no lifestyle changes needed and no program to ... day. , The starter kit contains 60 servings of nutritional ... of protein, fiber, healthy fat and complex carbohydrates that helps ...
Breaking Medicine News(10 mins):Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 3Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 3Health News:6 Wintertime Weight Loss Tips for Family Fitness Presented by Community Health Center of Snohomish County in Recent Article 2Health News:Prophecy Healthcare Acquires IP to Expand Behavioral Benchmarks 2Health News:Prophecy Healthcare Acquires IP to Expand Behavioral Benchmarks 3Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 2Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 3
... Drug Administration (FDA) have approved a virus mix in spray ... given last month.// , ,Processed meats after being ... is a combination of viruses that kill this bacteria. Food ... and distribution. ,This virus mix is not effective ...
... crisp habit is prevalent among 55% of the British children and ... ,The BHF started a campaign to create awareness among ... common foods and the figures were releases as a part of ... oil, salt and sugar as we and our children continue to ...
... actors, echoed The Bard, eons ago. As the curtains go ... today on// World Alzheimer’s day, the stage is set for deep ... and evolve better strategies for effective management of the disease. ... nervous system marked by stark and untimely backslide in the patient’s ...
... biological markers that can predict disability, morbidity and ... researchers// analyzed 13 biomarkers representing neuroendocrine and vascular ... years in 1,189 high-functioning men and women aged ... Aging. The goals were to identify biomarker combinations ...
... over plans of British hospitals to outsource medical transcription to ... are not shelved.// ,Several hospitals in Britain have outsourced ... typing up patients' notes to India to save costs at ... hospitals in Staffordshire, Leeds and Cornwall. ,At the ...
... reported having updated the warning label on the Ortho ... of blood clots from it.// ,The drug manufacturer ... faced two times the risk of clots in the ... pills. ,Another study commissioned by Johnson and Johnson, ...
Cached Medicine News:Health News:World Alzheimer’s Day: In Memory of Those With 'Memory Loss 2Health News:World Alzheimer’s Day: In Memory of Those With 'Memory Loss 3Health News:Britain Hospital Staff Threatens Strike 2Health News:Contraceptive Patch Carries Risk of Blood clots 2
... automated patient ID verification and laboratory specimen labeling ... of the phlebotomist or nurse, the identity of ... proper verification is made, a bar coded sample ... Its unique design simplifies and eliminates the interface ...
... Bridge™ Specimen Collections, a Cerner ... for specimen identification and collection. The ... of the specimen collections process by ... and clinical information system integration to ...
... bar-code medication administration solution that safely automates ... bar-code technology. Caregivers use a wireless bar-code ... to verify that the right patient receives ... in the right dosage via the right ...
... Korchek Technologies CareChek ... employs barcode technology, Windows ... with integrated scanners (to ... at the bedside) and ...
Medicine Products: